본문 바로가기
KERD
논문KCI 등재

기분조절제로 인한 인지기능 부작용이 동반된 양극성 기분장애 환자의 임상적인 특징: 아시아의 정신작용약물 처방 경향 연구(REAP-BD Survey) 중 국내 자료 활용

Clinical Characteristics of Bipolar Disorder Patients with Mood Stabilizer-Induced Cognitive Side Effects findings from the REAP-BD Survey in Korea

김기원|박용천|최진희|최하연|소형석|박선철|신희현|Chay Hoon Tan|Shih-ku Lin|Naotaka Shinfuku
대한신경정신의학회 (Korean Neuropsychiatric Association)|2020.08|신경정신의학 (JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION)|제59권 제3호|pp. 277-284|DOI https://doi.org/10.4306/jknpa.2020.59.3.277

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류정신과학

초록

Objectives This study aimed to identify differences between bipolar disorder patients who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers. Methods This study analyzed 350 Korean adults who were diagnosed with bipolar disorder and prescribed mood-stabilizing drugs. The patients were divided into two groups—patients who experienced cognitive side effects and those who did not experience cognitive side effects. We also compared the demographic and clinical characteristics between both groups. Results The number of patients with an untreated illness longer than 1 year was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. Further, the number of patients with manic symptoms at onset was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. In addition, the proportion of patients in remission was higher in the group of patients who experienced cognitive side effects compared to the group of patients who experienced no cognitive side effects. However, there was no significant difference regarding the type of mood stabilizer used between the groups. On the other hand, more people experienced cognitive side effects as the valproic acid dosage increased. Conclusion Our findings suggest that there are clinical and demographic differences between people who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers.

Abstract

Objectives This study aimed to identify differences between bipolar disorder patients who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers. Methods This study analyzed 350 Korean adults who were diagnosed with bipolar disorder and prescribed mood-stabilizing drugs. The patients were divided into two groups—patients who experienced cognitive side effects and those who did not experience cognitive side effects. We also compared the demographic and clinical characteristics between both groups. Results The number of patients with an untreated illness longer than 1 year was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. Further, the number of patients with manic symptoms at onset was higher in the group of patients who experienced cognitive side effects compared to the group of patients who did not experience cognitive side effects. In addition, the proportion of patients in remission was higher in the group of patients who experienced cognitive side effects compared to the group of patients who experienced no cognitive side effects. However, there was no significant difference regarding the type of mood stabilizer used between the groups. On the other hand, more people experienced cognitive side effects as the valproic acid dosage increased. Conclusion Our findings suggest that there are clinical and demographic differences between people who experienced cognitive side effects and those who did not experience cognitive side effects due to prescription of mood stabilizers.

참고문헌 (36)

  1. Newcomer JW, "Medical risk in patients with bipolar disorder and schizophrenia", J Clin Psychiatry, 67, pp.25~30 (2006)
  2. Young AH, "Physical health of patients with bipolar disorder", Acta Psychiatr Scand Suppl, 127, pp.3~10 (2013)
  3. Pompili M, "Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk", Expert Rev Neurother, 9, pp.985~1004 (2009)
  4. Scott J, "Cognitive vulnerability in patients with bipolar disorder", Psychol Med, 30, pp.467~472 (2000)
  5. Vasile D, "Evaluation of the mood-stabilizers associated neurocognitive effects in bipolar patients", Therapeutics, Pharmacology and Clinical Toxicology, 15, pp.304~308 (2011)
  6. Karanti A, "Changes in mood stabilizer prescription patterns in bipolar disorder", J Affect Disord, 195, pp.50~56 (2016)
  7. Dias VV, "Pharmacological approaches in bipolar disorders and the impact on cognition : a critical overview", Acta Psychiatr Scand, 126, pp.315~331 (2012)
  8. Gualtieri CT, "Comparative neurocognitive effects of 5psychotropic anticonvulsants and lithium", MedGenMed, 8, pp.46~ (2006)
  9. Shaw ED, "Effects of lithium carbonate on associative productivity and idiosyncrasy in bipolar outpatients", Am J Psychiatry, 143, pp.1166~1169 (1986)
  10. Senturk V, "Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate", Bipolar Disord, 9, pp.136~144 (2007)
  11. Khan A, "Effect of lamotrigine on cognitive complaints in patients with bipolar I disorder", J Clin Psychiatry, 65, pp.1483~1490 (2004)
  12. Bora E, "The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients", Bipolar Disord, 9, pp.468~477 (2007)
  13. Martínez-Arán A, "Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder", Am J Psychiatry, 161, pp.262~270 (2004)
  14. Kocsis JH, "Neuropsychologic effects of lithium discontinuation", J Clin Psychopharmacol, 13, pp.268~275 (1993)
  15. Berk M, "Mood stabilizers and treatment adherence in bipolar disorder : addressing adverse events", Ann Clin Psychiatry, 15, pp.217~224 (2003)
  16. Kiwon Kim, "Examining Patterns of Polypharmacy in Bipolar Disorder: Findings from the REAP-BD, Korea", PSYCHIATRY INVESTIGATION, 16(5), pp.397~402 (2019), 대한신경정신의학회[DOI]
  17. Seon-Cheol Park, "Clinical Characteristics and Psychotropic Drug Prescription Patterns of Bipolar Disorder Patients with a History of Suicidal Attempts: Findings from the REAP-BD, Korea", PSYCHIATRY INVESTIGATION, 16(6), pp.459~463 (2019), 대한신경정신의학회[DOI]
  18. World Health Organization, "The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines" (1992), World Health Organization
  19. Fellinger M, "Seasonality in bipolar disorder : effect of sex and age", J Affect Disord, 243, pp.322~326 (2019)
  20. Nahler G, "Dictionary of pharmaceutical medicine" (2009), Springer
  21. Solé B, "Cognitive impairment in bipolar disorder : treatment and prevention strategies", Int J Neuropsychopharmacol, 20, pp.670~680 (2017)
  22. López-Jaramillo C, "Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder", J Clin Psychiatry, 71, pp.1055~1060 (2010)
  23. Wollenhaupt-Aguiar B, "Reduced neurite density in neuronal cell cultures exposed to serum of patients with bipolar disorder", Int J Neuropsychopharmacol, 19, pp.pyw051~ (2016)
  24. Daban C, "Clinical correlates of first-episode polarity in bipolar disorder", Compr Psychiatry, 47, pp.433~437 (2006)
  25. Perugi G, "Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients", Compr Psychiatry, 41, pp.13~18 (2000)
  26. Jawad I, "Medication nonadherence in bipolar disorder : a narrative review", Ther Adv Psychopharmacol, 8, pp.349~363 (2018)
  27. Hukic DS, "Cognitive manic symptoms in bipolar disorder associated with polymorphisms in the DAOA and COMT genes", PLoS One, 8, pp.e67450~ (2013)
  28. Mert DG, "Mean platelet volume in bipolar disorder : the search for an ideal biomarker", Neuropsychiatr Dis Treat, 12, pp.2057~2062 (2016)
  29. Stellos K, "Predictive value of platelet activation for the rate of cognitive decline in Alzheimer’s disease patients", J Cereb Blood Flow Metab, 30, pp.1817~1820 (2010)
  30. Campbell N, "The cognitive impact of anticholinergics : a clinical review", Clin Interv Aging, 4, pp.225~233 (2009)
  31. MacKenzie NE, "Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia", Front Psychiatry, 9, pp.622~ (2018)
  32. Keefe RS, "Cognitive effects of pharmacotherapy for major depressive disorder : a systematic review", J Clin Psychiatry, 75, pp.864~876 (2014)
  33. Hindmarch I, "Cognition and anxiety : the cognitive effects of antianxiety medication", Acta Psychiatr Scand Suppl, 393, pp.89~94 (1998)
  34. Bauer IE, "Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder : a diffusion tensor imaging study", J Psychiatr Res, 62, pp.115~122 (2015)
  35. Engelsmann F, "Lithium treatment and memory assessment : methodology", Neuropsychobiology, 26, pp.113~119 (1992)
  36. Meador KJ, "Differential cognitive and behavioral effects of topiramate and valproate", Neurology, 60, pp.1483~1488 (2003)

관련 논문AI추천

Examining Patterns of Polypharmacy in Bipolar Disorder: Findings from the REAP-BD, KoreaByung-Joo Ham, Chay-Hoon Tan, Euihyeon Na, Hong Seok Oh, Hoseon Lee, Hyung-Jun Yoon, Hyunju Yang, Kiwon Kim, Naotaka Shinfuku, Ok-Jin Jang, Seon-Cheol Park, Shih-Ku Lin, Yong Chon Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2019 · 제16권 제5호소아청소년기 발병 양극성 장애와 성인기 발병 양극성 장애의 인지 및 임상적 특성에 대한 비교 연구김대욱, 김성곤, 김지훈, 김현미, 유은라, 윤동욱, 정우영, 최범성, 허성영대한생물치료정신의학회 · 생물치료정신의학2020 · 제26권 제2호기분안정기의 I형 양극성 장애에서 신경인지기능김지혜, 소형석, 송진관, 안석균, 이상민, 이충헌, 정혜정, 조현상대한신경정신의학회 · 신경정신의학2002 · 제41권 제4호Clinical Characteristics and Psychotropic Drug Prescription Patterns of Bipolar Disorder Patients with a History of Suicidal Attempts: Findings from the REAP-BD, Korea이정구, Chay-Hoon Tan, Dong-Woo Lee, Joonho Choi, Joon Hyuk Park, Kiwon Kim, Naotaka Shinfuku, Ok-Jin Jang, Seon-Cheol Park, Seung-Gon Kim, Shih-Ku Lin, Yong Chon Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2019 · 제16권 제6호한국형 양극성 장애 약물치료 알고리듬 2022: 노인김원, 김문두, 박성용, 박원명, 서정석, 손인기, 심세훈, 양찬모, 우영섭, 윤보현, 이정구, 전덕인, 정명훈, 정종현, 추일한대한신경정신의학회 · 신경정신의학2022 · 제61권 제4호Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar DisorderAfzal Javed, Ajit Avasthi, Chay Hoon Tan, Kohei Hayakawa, Kok Yoon Chee, Lakmi Seneviratne, Margarita Maramis, Mian-Yoon Chong, M. Nasar Sayeed Khan, Naotaka Shinfuku, Norliza Chemi, Norman Sartorius, Ok-Jin Jang, Pornjira Pariwatcharakul, Roy Abraham Kallivayalil, Sandeep Grover, Seon-Cheol Park, Shih-Ku Lin, Shu-Yu Yang, Sim Kang, Takahiro A. Kato, Tin Oo, Wai Kwong Tang, Wen-Chen Ouyang, Xiaomin Zhu, Yong Chon Park, Yu-Tao Xiang대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제1호

이 간행물의 다른 논문 (13건)

소아청소년정신의학 분야에서 시행되는 정책적 접근 및 인접 분야와의 통섭박민현pp. 175-175영유아건강검진 사업에서 소아정신과 전문의의 역할반건호pp. 176-184정신건강의학과 의사가 문화적 역량을 갖추고 다양한 문화적 배경을 가진 소아청소년 환자와 가족을 면담하는 법정운선pp. 185-195아동 성폭력과 정부지원 아동 성폭력 지원기관 (해바라기센터)송동호pp. 196-201소아·청소년에 대한 만사형통형 모델조수철pp. 202-207
원문 보기